| Pharmaceutical active ingredients: |
| Sotalol Hydrochloride |
| Available forms, composition and doses of Betapace AF: |
| Tablets; Oral; Sotalol Hydrochloride 100 mgTablets; Oral; Sotalol Hydrochloride 120 mgTablets; Oral; Sotalol Hydrochloride 160 mgTablets; Oral; Sotalol Hydrochloride 40 mgTablets; Oral; Sotalol Hydrochloride 60 mgTablets; Oral; Sotalol Hydrochloride 80 mg |
| Betapace AF medical category: |
| Human:Beta-adrenergic blocking agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C07AA07 - Sotalol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering PharmaBerlex Laboratories |
| Related documents and information about Betapace AF: |
| Betapace prescribing information (PDF)Betapace AF prescribing information (PDF) |